Article(id=1329905773729133489, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905755949478607, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.08.006, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1735228800000, receivedDateStr=2024-12-27, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795003844911, onlineDateStr=2026-11-18, pubDate=1754755200000, pubDateStr=2025-08-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795003844911, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795003844911, creator=13701087609, updateTime=1795003844911, updator=13701087609, issue=Issue{id=1329905755949478607, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='8', pageStart='975', pageEnd='1108', issueExtLink='null', onlineDate='null', pubDate='1754755200000', pubDateStr='2025-08-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1795003840672, creator='13701087609', updateTime=1795004363274, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329907948366705176, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905755949478607, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329907948366705177, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905755949478607, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1011, endPage=1016, ext={EN=ArticleExt(id=1329905773943042994, articleId=1329905773729133489, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=A Novel Synthetic Method of the Intermediate of Deucravacitinib, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=

Herein, a new three-step synthetic route for the key intermediate of the tyrosine kinase 2(TYK2)inhibitor deucravacitinib, 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline(1) was described. N'-Hydroxy-2-methoxy-3-nitrobenzimidamide(3) was prepared via one-pot etherification/addition reaction of 2-fluoro-3-nitrobenzonitrile(2) with methanol and hydroxylamine hydrochloride in the presence of potassium hydroxide and tetrabutylammonium bromide.The esterification of compound 3 with tosyl chloride gave N'-(tosyloxy)benzimidamide(4), without further separation and purification, which was directly subjected to the condensation cyclization with methanamine hydrochloride and triethoxymethane to afford 3-(2-methoxy-3-nitrophenyl)-1-methyl-1H-1,2,4-triazole(5). Compound 5 was reduced by thiourea dioxide in the presence of sodium hydroxide to obtain the target product 1 with overall yield of 76%(based on 2)and purity of 99.3%. This new synthetic route has fewer reaction steps, higher overall yield, good selectivity, safe operation,which avoids the use of toxic hydrazine (or its derivatives) to construct 1,2,4-triazoles.

, authors=Changchun LIU, Xinxin ZHOU, Chun XUE, authorsList=Changchun LIU, Xinxin ZHOU, Chun XUE, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329905774228255667, articleId=1329905773729133489, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=氘可来昔替尼中间体的合成新方法, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

文章报道了酪氨酸激酶2(TYK2)抑制剂氘可来昔替尼关键中间体,2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺(1)的合成新路线,仅3步反应。2-氟-3-硝基苯甲腈(2)在氢氧化钾和四丁基溴化铵存在下,与甲醇和盐酸羟胺经“一锅法”进行醚化/加成反应,得N'-羟基-2-甲氧基-3-硝基苯甲脒(3)。3与对甲苯磺酰氯(TsCl)发生酯化反应,生成中间体N'-(对甲苯磺酰氧基)苯甲脒(4),无需进一步分离、纯化,直接与甲胺盐酸盐和原甲酸三乙酯缩合、环化,得3-(2-甲氧基-3-硝基苯基)-1-甲基-1H-1,2,4-三唑(5)。5在氢氧化钠存在下,经二氧化硫脲还原得目标产物1。总收率76%(以2计),纯度99.3%。该路线步骤少、收率高、选择性良好、操作安全,能避免使用有毒试剂肼(或其衍生物)构建1,2,4-三唑环。

, authors=刘长春, 周鑫鑫, 薛纯, authorsList=刘长春, 周鑫鑫, 薛纯, authorCompany=null, correspAuthors=null, authorNote=

刘长春,教授,从事药物合成的研究。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=ng2cfYlxMptIRzxGmtg7hA==, magXml=/EmxCS+8rTMEI6fcjHB0lg==, pdfUrl=null, pdf=Uv6pfdbJz0Q4ANYbS3/3/g==, pdfFileSize=1115230, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=TobySY+hKdJ2PpUm4+f9tw==, mapNumber=null, fund=null)}, authors=[Author(id=1329905774492496824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905774576382906, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774492496824, language=EN, stringName=Changchun LIU, firstName=Changchun, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905774643491771, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774492496824, language=CN, stringName=刘长春, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003, bio={"content":"

刘长春,教授,从事药物合成的研究。

"}, bioImg=null, bioContent=

刘长春,教授,从事药物合成的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905774416999348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, xref=null, ext=[AuthorCompanyExt(id=1329905774425387957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003), AuthorCompanyExt(id=1329905774433776566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003)])]), Author(id=1329905774698017725, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905774765126591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774698017725, language=EN, stringName=Xinxin ZHOU, firstName=Xinxin, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905774836429760, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774698017725, language=CN, stringName=周鑫鑫, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905774416999348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, xref=null, ext=[AuthorCompanyExt(id=1329905774425387957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003), AuthorCompanyExt(id=1329905774433776566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003)])]), Author(id=1329905774895150019, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905774970647493, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774895150019, language=EN, stringName=Chun XUE, firstName=Chun, middleName=null, lastName=XUE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905775033562054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774895150019, language=CN, stringName=薛纯, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905774416999348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, xref=null, ext=[AuthorCompanyExt(id=1329905774425387957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003), AuthorCompanyExt(id=1329905774433776566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003)])])], keywords=[Keyword(id=1329905775146808263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, language=EN, orderNo=1, keyword=2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline), Keyword(id=1329905775213917128, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, language=EN, orderNo=2, keyword=deucravacitinib), Keyword(id=1329905775281025993, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, language=EN, orderNo=3, keyword=tyrosine kinase 2 inhibitor), Keyword(id=1329905775343940554, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, language=EN, orderNo=4, keyword=intermediate), Keyword(id=1329905775402660811, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, language=EN, orderNo=5, keyword=synthesis), Keyword(id=1329905775465575372, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, language=CN, orderNo=1, keyword=2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺), Keyword(id=1329905775536878541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, language=CN, orderNo=2, keyword=氘可来昔替尼), Keyword(id=1329905775599793102, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, language=CN, orderNo=3, keyword=酪氨酸激酶2抑制剂), Keyword(id=1329905775683679183, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, language=CN, orderNo=4, keyword=中间体), Keyword(id=1329905775746593744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, language=CN, orderNo=5, keyword=合成)], refs=[Reference(id=1329905775926948818, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=BLAUVELT A, RICH P, SOFEN H, et al.Deucravacitinib,a selective, allosterictyrosine kinase 2 inhibitor, in scalppsoriasis: a subset analysis of two phase3 randomized trials in plaque psoriasis [J].J Am Acad Dermatol, 2024,90(4): 775-782., articleTitle=null, refAbstract=null), Reference(id=1329905775998251987, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Novel drug approvals for 2022 [EB/OL].[2022-09-09].https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2022., articleTitle=null, refAbstract=null), Reference(id=1329905776061166548, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=毕思举, 林快乐, 刘玲玲, 等.2022年美国FDA批准上市的新药简介[J].中国医药工业杂志, 2023, 54(1): 1-18., articleTitle=null, refAbstract=null), Reference(id=1329905776132469717, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=李嘉怡, 王翰丞, 张 涵, 等.药物分子氘代修饰方法研究进展[J].中国医药工业杂志, 2024, 55(11): 1449-1466., articleTitle=null, refAbstract=null), Reference(id=1329905776199578582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG S, NING W, TANG H, et al.Efficacy and safety study of targeted smallmoleculedrugs in the treatment of systemiclupus erythematosus [J].Arthritis Res Ther, 2024,26(1): 98., articleTitle=null, refAbstract=null), Reference(id=1329905776275076055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=MORAND E, MEROLA J F, TANAKA Y, et al.TYK2: an emerging therapeutic target in rheumatic disease[J].Nat Rev Rheumatol, 2024, 20(4), 232-240., articleTitle=null, refAbstract=null), Reference(id=1329905776342184920, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=WROBLESKI S T, MOSLIN R, LIN S, et al.Highly selective inhibition of tyrosine kinase 2 (TYK2) for the treatment of autoimmune diseases: discovery of the allosteric inhibitor BMS-986165 [J].J Med Chem, 2019, 62(20):8973-8995., articleTitle=null, refAbstract=null), Reference(id=1329905776417682393, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=TREITLER D S, SOUMEILLANT M C, SIMMONS E M, et al. Development of a commercial process for deucravacitinib, a deuterated API for TYK2 inhibition [J].Org Process Res Dev, 2022, 26(4): 1202-1222., articleTitle=null, refAbstract=null), Reference(id=1329905776505762778, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=陈君豪, 茆勇军, 刘 威, 等.2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺的制备方法: 中国, 118184591A[P].2024-06-14., articleTitle=null, refAbstract=null), Reference(id=1329905776568677339, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=郑旭春, 张一平, 付晨晨.一种2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺的制备方法: 中国, 114989103B[P].2024-07-09., articleTitle=null, refAbstract=null), Reference(id=1329905776665146332, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=秦天洪, 旷玉龙, 王学超, 等.一种氘可来昔替尼中间体的制备方法: 中国, 117447353A [P].2024-01-26., articleTitle=null, refAbstract=null), Reference(id=1329905776744838109, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=刘 豪, 黎柏晨, 王 建, 等.一种2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺的制备方法: 中国,117247360A [P].2023-12-19., articleTitle=null, refAbstract=null), Reference(id=1329905776811946974, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=李丕旭, 王 鹏, 周 鹏.一种杂环药物中间体的合成方法:中国, 117447411A [P].2024-01-26., articleTitle=null, refAbstract=null), Reference(id=1329905776887444447, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=陈梦雅, 吴 诗.2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺的合成工艺研究[J].湖北科技学院学报(医学版), 2020, 34(4): 293-295., articleTitle=null, refAbstract=null), Reference(id=1329905776954553312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=TAM A, ARMSTRONG I S, LA CRUZ T E.Multicomponent synthesis of 1-aryl 1,2,4-triazoles [J].Org Lett, 2013,15(14): 3586-3589., articleTitle=null, refAbstract=null), Reference(id=1329905777017467873, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=LA CRUZ T E, TREITLER D S, TAM A, et al.Process development and scale-up of a multicomponent synthesis of a 3-methyl-1-aryl-1,2,4-triazole building block [J].Org Process Res Dev, 2020, 24(2): 279-285., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329905775838868433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, awardId=HAB201916, language=CN, fundingSource=淮安市自然科学研究计划项目(HAB201916), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329905774416999348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, xref=null, ext=[AuthorCompanyExt(id=1329905774425387957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003), AuthorCompanyExt(id=1329905774433776566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.08.006, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.08.006, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.08.006, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.08.006, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1754755200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
氘可来昔替尼中间体的合成新方法
刘长春 , 周鑫鑫 , 薛纯
中国医药工业杂志 | 研究论文 2025,56(8): 1011-1016
收起
收藏切换
中国医药工业杂志 |研究论文 2025 , 56 (8) : 1011 -1016
氘可来昔替尼中间体的合成新方法
全屏
[Author(id=1329905774492496824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905774576382906, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774492496824, language=EN, stringName=Changchun LIU, firstName=Changchun, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905774643491771, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774492496824, language=CN, stringName=刘长春, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003, bio={"content":"

刘长春,教授,从事药物合成的研究。

"}, bioImg=null, bioContent=

刘长春,教授,从事药物合成的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905774416999348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, xref=null, ext=[AuthorCompanyExt(id=1329905774425387957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003), AuthorCompanyExt(id=1329905774433776566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003)])]), Author(id=1329905774698017725, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905774765126591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774698017725, language=EN, stringName=Xinxin ZHOU, firstName=Xinxin, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905774836429760, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774698017725, language=CN, stringName=周鑫鑫, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905774416999348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, xref=null, ext=[AuthorCompanyExt(id=1329905774425387957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003), AuthorCompanyExt(id=1329905774433776566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003)])]), Author(id=1329905774895150019, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905774970647493, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774895150019, language=EN, stringName=Chun XUE, firstName=Chun, middleName=null, lastName=XUE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905775033562054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, authorId=1329905774895150019, language=CN, stringName=薛纯, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905774416999348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, xref=null, ext=[AuthorCompanyExt(id=1329905774425387957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003), AuthorCompanyExt(id=1329905774433776566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905773729133489, companyId=1329905774416999348, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003)])])]
刘长春, 周鑫鑫, 薛纯
作者信息
  • 江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003
作者简介:

刘长春,教授,从事药物合成的研究。

A Novel Synthetic Method of the Intermediate of Deucravacitinib
Changchun LIU, Xinxin ZHOU, Chun XUE
Affiliations
  • School of Pharmaceutical Engineering, Jiangsu Food and Pharmaceutical Science College, Huaian 223003
出版时间: 2025-08-10 doi: 10.16522/j.cnki.cjph.2025.08.006
文章导航
收藏切换

文章报道了酪氨酸激酶2(TYK2)抑制剂氘可来昔替尼关键中间体,2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺(1)的合成新路线,仅3步反应。2-氟-3-硝基苯甲腈(2)在氢氧化钾和四丁基溴化铵存在下,与甲醇和盐酸羟胺经“一锅法”进行醚化/加成反应,得N'-羟基-2-甲氧基-3-硝基苯甲脒(3)。3与对甲苯磺酰氯(TsCl)发生酯化反应,生成中间体N'-(对甲苯磺酰氧基)苯甲脒(4),无需进一步分离、纯化,直接与甲胺盐酸盐和原甲酸三乙酯缩合、环化,得3-(2-甲氧基-3-硝基苯基)-1-甲基-1H-1,2,4-三唑(5)。5在氢氧化钠存在下,经二氧化硫脲还原得目标产物1。总收率76%(以2计),纯度99.3%。该路线步骤少、收率高、选择性良好、操作安全,能避免使用有毒试剂肼(或其衍生物)构建1,2,4-三唑环。

2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺  /  氘可来昔替尼  /  酪氨酸激酶2抑制剂  /  中间体  /  合成

Herein, a new three-step synthetic route for the key intermediate of the tyrosine kinase 2(TYK2)inhibitor deucravacitinib, 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline(1) was described. N'-Hydroxy-2-methoxy-3-nitrobenzimidamide(3) was prepared via one-pot etherification/addition reaction of 2-fluoro-3-nitrobenzonitrile(2) with methanol and hydroxylamine hydrochloride in the presence of potassium hydroxide and tetrabutylammonium bromide.The esterification of compound 3 with tosyl chloride gave N'-(tosyloxy)benzimidamide(4), without further separation and purification, which was directly subjected to the condensation cyclization with methanamine hydrochloride and triethoxymethane to afford 3-(2-methoxy-3-nitrophenyl)-1-methyl-1H-1,2,4-triazole(5). Compound 5 was reduced by thiourea dioxide in the presence of sodium hydroxide to obtain the target product 1 with overall yield of 76%(based on 2)and purity of 99.3%. This new synthetic route has fewer reaction steps, higher overall yield, good selectivity, safe operation,which avoids the use of toxic hydrazine (or its derivatives) to construct 1,2,4-triazoles.

2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline  /  deucravacitinib  /  tyrosine kinase 2 inhibitor  /  intermediate  /  synthesis
刘长春, 周鑫鑫, 薛纯. 氘可来昔替尼中间体的合成新方法. 中国医药工业杂志, 2025 , 56 (8) : 1011 -1016 . DOI: 10.16522/j.cnki.cjph.2025.08.006
Changchun LIU, Xinxin ZHOU, Chun XUE. A Novel Synthetic Method of the Intermediate of Deucravacitinib[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (8) : 1011 -1016 . DOI: 10.16522/j.cnki.cjph.2025.08.006
  • 淮安市自然科学研究计划项目(HAB201916)
参考文献 引证文献
排序方式:
[1]
BLAUVELT A, RICH P, SOFEN H, et al.Deucravacitinib,a selective, allosterictyrosine kinase 2 inhibitor, in scalppsoriasis: a subset analysis of two phase3 randomized trials in plaque psoriasis [J].J Am Acad Dermatol, 2024,90(4): 775-782.
[2]
FDA.Novel drug approvals for 2022 [EB/OL].[2022-09-09].https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2022.
[3]
毕思举, 林快乐, 刘玲玲, 等.2022年美国FDA批准上市的新药简介[J].中国医药工业杂志, 2023, 54(1): 1-18.
[4]
李嘉怡, 王翰丞, 张 涵, 等.药物分子氘代修饰方法研究进展[J].中国医药工业杂志, 2024, 55(11): 1449-1466.
[5]
WANG S, NING W, TANG H, et al.Efficacy and safety study of targeted smallmoleculedrugs in the treatment of systemiclupus erythematosus [J].Arthritis Res Ther, 2024,26(1): 98.
[6]
MORAND E, MEROLA J F, TANAKA Y, et al.TYK2: an emerging therapeutic target in rheumatic disease[J].Nat Rev Rheumatol, 2024, 20(4), 232-240.
[7]
WROBLESKI S T, MOSLIN R, LIN S, et al.Highly selective inhibition of tyrosine kinase 2 (TYK2) for the treatment of autoimmune diseases: discovery of the allosteric inhibitor BMS-986165 [J].J Med Chem, 2019, 62(20):8973-8995.
[8]
TREITLER D S, SOUMEILLANT M C, SIMMONS E M, et al. Development of a commercial process for deucravacitinib, a deuterated API for TYK2 inhibition [J].Org Process Res Dev, 2022, 26(4): 1202-1222.
[9]
陈君豪, 茆勇军, 刘 威, 等.2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺的制备方法: 中国, 118184591A[P].2024-06-14.
[10]
郑旭春, 张一平, 付晨晨.一种2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺的制备方法: 中国, 114989103B[P].2024-07-09.
[11]
秦天洪, 旷玉龙, 王学超, 等.一种氘可来昔替尼中间体的制备方法: 中国, 117447353A [P].2024-01-26.
[12]
刘 豪, 黎柏晨, 王 建, 等.一种2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺的制备方法: 中国,117247360A [P].2023-12-19.
[13]
李丕旭, 王 鹏, 周 鹏.一种杂环药物中间体的合成方法:中国, 117447411A [P].2024-01-26.
[14]
陈梦雅, 吴 诗.2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺的合成工艺研究[J].湖北科技学院学报(医学版), 2020, 34(4): 293-295.
[15]
TAM A, ARMSTRONG I S, LA CRUZ T E.Multicomponent synthesis of 1-aryl 1,2,4-triazoles [J].Org Lett, 2013,15(14): 3586-3589.
[16]
LA CRUZ T E, TREITLER D S, TAM A, et al.Process development and scale-up of a multicomponent synthesis of a 3-methyl-1-aryl-1,2,4-triazole building block [J].Org Process Res Dev, 2020, 24(2): 279-285.
2025年第56卷第8期
47
14
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2025.08.006
  • 接收时间:2024-12-27
  • 首发时间:2026-11-18
  • 出版时间:2025-08-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-12-27
基金
淮安市自然科学研究计划项目(HAB201916)
作者信息
    江苏食品药品职业技术学院制药工程学院,江苏 淮安 223003
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.08.006
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏